ATC Group: J06BD04 Ansuvimab

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J06BD04 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J06 Immune sera and immunoglobulins
3 J06B Immunoglobulins
4 J06BD Antiviral monoclonal antibodies
5 J06BD04

Active ingredients in J06BD04

Active Ingredient

Ansuvimab is a recombinant human monoclonal antibody with antiviral activity against Zaire ebolavirus.

Related product monographs

Document Type Information Source  
 EBANGA Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)

United States medicines